TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2254714

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg d-1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Indomethacin (75 mg d-1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Diclophenac sodium (75 mg d-1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Second drug (when fever relapsed)
Number of subjects: 48
Study: 6793609

Group type: EXPERIMENTAL
Intervention: Pergolide (100 micrograms orally)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31905041

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA) - Group 1
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA) - Group 2
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA) - Group 3
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 105
Study: 31146380

Group type: EXPERIMENTAL
Intervention: COANT (diet with vitamin E and selenium as antioxidants)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OANT (diet with sunflower oil containing more vitamin E and selenium as antioxidants)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OIL (diet with sunflower oil)
Number of subjects: 100

Group type: COMPARATOR
Intervention: SM (skim milk)
Number of subjects: 100
Study: 28104105

Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Valsartan 160mg
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg + Valsartan 80mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control (low-dose monotherapy)
Number of subjects: 134
Study: 27091813

Group type: EXPERIMENTAL
Intervention: Virtual team intervention including social work evaluation, team-based electronic consultation, case management, and psychotherapy over a 12 month period.
Number of subjects: 250

Group type: COMPARATOR
Intervention: Membership program providing health classes and other services to support chronic disease self-management.
Number of subjects: 250
Study: 25301296

Group type: EXPERIMENTAL
Intervention: Iron supplementation (30 mg Fe daily as FeSO4-containing syrup for eight weeks starting immediately after malaria treatment)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Delayed iron supplementation (30 mg Fe daily as FeSO4-containing syrup for eight weeks starting two weeks after malaria treatment)
Number of subjects: 48
Study: 22453267

Group type: EXPERIMENTAL
Intervention: TVT-S
Number of subjects: 87

Group type: COMPARATOR
Intervention: TVT-O
Number of subjects: 87
Study: 21242610

Group type: EXPERIMENTAL
Intervention: Maximal treadmill test
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cross-validation statistics
Number of subjects: 88
Study: 18051006

Group type: EXPERIMENTAL
Intervention: Vertical grooves in the buccal and lingual walls (G2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: "Pot holes" in the gingival wall (G3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Horizontal grooves in the gingival wall (G4)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No retention (G1)
Number of subjects: 40
Study: 16139121

Group type: EXPERIMENTAL
Intervention: Stent implantation (ST) arm
Number of subjects: 450

Group type: COMPARATOR
Intervention: Balloon angioplasty (BA) arm
Number of subjects: 450
Study: 12010235

Group type: EXPERIMENTAL
Intervention: Propionyl-l-carnitine (2 g/day for 3 months) plus verapamil (10 mg weekly for 10 weeks)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Tamoxifen (40 mg/day for 3 months) plus verapamil (10 mg weekly for 10 weeks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Propionyl-l-carnitine plus verapamil
Number of subjects: 75
Study: 9390113

Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg dexamethasone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg dexamethasone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 9
Study: 8133126

Group type: EXPERIMENTAL
Intervention: Ambulatory ST-recording
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Exercise test
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High risk exercise test response
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Severe coronary lesions
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ST-depression during ST-recording
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ST-depression at ambulatory monitoring
Number of subjects: 95
Study: 3310020

Group type: EXPERIMENTAL
Intervention: nabumetone (1000 mg at bedtime)
Number of subjects: 40

Group type: COMPARATOR
Intervention: naproxen (250 mg twice daily)
Number of subjects: 40
Study: 29363990

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 27301220

Group type: EXPERIMENTAL
Intervention: Nutritional education and dietary intervention for six months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 90
Study: 25257291

Group type: EXPERIMENTAL
Intervention: Org 25935 12 mg twice a day
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 22282868

Group type: EXPERIMENTAL
Intervention: Medium/long-chain triglycerides and soybean oil (MCTs/LCTs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pure fish oil (FO)
Number of subjects: 25
Study: 20660003

Group type: EXPERIMENTAL
Intervention: Tumour size >2 cm
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: pT4a-category
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Tumour size
Number of subjects: 351

Group type: COMPARATOR
Intervention: pT3b-tumours
Number of subjects: 351

Group type: COMPARATOR
Intervention: Follicular thyroid carcinomas (FTC)
Number of subjects: 351
Study: 18768436

Group type: EXPERIMENTAL
Intervention: Epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil (epi-CMF)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 322
Study: 15707567

Group type: EXPERIMENTAL
Intervention: Simply modified no-scalpel vasectomy (SMNSV)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Standard no-scalpel vasectomy (SNSV)
Number of subjects: 417
Study: 12407126

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg, amoxicillin 1 g and clarithromycin 500 mg (triple therapy)
Number of subjects: 12
Study: 10630486

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (400 mg twice daily), clarithromycin (500 mg twice daily), and tinidazole (500 mg twice daily) for six days (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (400 mg twice daily), clarithromycin (500 mg twice daily), and tinidazole (500 mg twice daily) for seven days (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 7574903

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no multivitamin supplementation)
Number of subjects: 0
Study: 1670598

Group type: EXPERIMENTAL
Intervention: d-tubocurarine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: vecuronium
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: pancuronium
Number of subjects: 32

Group type: COMPARATOR
Intervention: saline
Number of subjects: 32

Group type: COMPARATOR
Intervention: succinylcholine
Number of subjects: 32
Study: 6340412

Group type: EXPERIMENTAL
Intervention: Indomethacin treatment for early closure of patent ductus arteriosus in 13 infants at a median age of 18 hours.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group of 14 infants with open ductus arteriosus who did not receive indomethacin.
Number of subjects: 37
Study: 30557916

Group type: EXPERIMENTAL
Intervention: Vibegron 50 mg/day
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Vibegron 100 mg/day
Number of subjects: 669

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Vibegron 50 mg/day and 100 mg/day
Number of subjects: 669
Study: 29769827

Group type: EXPERIMENTAL
Intervention: Very Low-Carbohydrate High-Fat (VLCHF) diet for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Habitual Mixed Western-based Diet (HD)
Number of subjects: 18
Study: 26386473

Group type: EXPERIMENTAL
Intervention: Snus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medicinal nicotine
Number of subjects: 0
Study: 24624241

Group type: EXPERIMENTAL
Intervention: McKenzie Protocol (MP)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MP plus Static Back Endurance Exercise Group (MPSBEEG)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MP plus Dynamic Endurance Exercise Group (MPDBEEG)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MP, MPSBEEG, MPDBEEG
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MPDBEEG
Number of subjects: 84
Study: 23276436

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 μg of selenium as selenium-yeast)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo (placebo-yeast tablet)
Number of subjects: 166
Study: 20678675

Group type: EXPERIMENTAL
Intervention: Barnidipine 10 mg plus losartan 50 mg
Number of subjects: 93

Group type: COMPARATOR
Intervention: Losartan 100 mg monotherapy
Number of subjects: 93
Study: 18247017

Group type: EXPERIMENTAL
Intervention: Erlotinib in combination with gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15781902

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Aerobic walking
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Combined resistance and aerobic walking
Number of subjects: 131

Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 131
Study: 12472549

Group type: EXPERIMENTAL
Intervention: Twice-daily dithranol in Lassar's paste
Number of subjects: 61

Group type: COMPARATOR
Intervention: Once-daily dithranol in Lassar's paste
Number of subjects: 61
Study: 9579002

Group type: EXPERIMENTAL
Intervention: IHDP intervention
Number of subjects: 0
Study: 7638914

Group type: EXPERIMENTAL
Intervention: Hot water systems with temperatures above 60 degrees C
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cold tap water and returning water temperatures
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Presence of Legionella pneumophila
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Serogroups of Legionella pneumophila
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Optimization of hot tap water systems
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Diagnostic consideration for primary atypical pneumonia
Number of subjects: 75
Study: 2930095

Group type: COMPARATOR
Intervention: Control (protocol for smoking management and a lecture on the consequences and management of smoking)
Number of subjects: 1420

Group type: EXPERIMENTAL
Intervention: Nicotine gum available to patients
Number of subjects: 1420

Group type: EXPERIMENTAL
Intervention: Stickers attached to smokers' charts (reminder)
Number of subjects: 1420

Group type: EXPERIMENTAL
Intervention: Both gum and reminders
Number of subjects: 1420
Study: 345986

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass with membrane and bubble oxygenators
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: In vitro aggregation tests with protamine sulfate and hemoglobin solutions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 14C‐serotonin tests
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Electron micrographs of platelets
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Measurement of blood loss, blood transfused, and plasma hemoglobin levels
Number of subjects: 40
Study: 30107477

Group type: EXPERIMENTAL
Intervention: Smooth surface tissue expanders (STE)
Number of subjects: 112
Study: 31189520

Group type: EXPERIMENTAL
Intervention: Oral semaglutide (flexible dose adjustments to 3, 7, or 14 mg once daily)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 504

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 504
Study: 27859100

Group type: EXPERIMENTAL
Intervention: Brief OurRelationship.com (Brief-OR) program with staff support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief OurRelationship.com (Brief-OR) program without staff support
Number of subjects: 0
Study: 26152818

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fosphenytoin
Number of subjects: 0
Study: 23571145

Group type: EXPERIMENTAL
Intervention: Transdermal amplitude modulated signal (TAMS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional stimuli
Number of subjects: 10
Study: 22091750

Group type: EXPERIMENTAL
Intervention: Decision aid on feeding options in advanced dementia
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 256
Study: 19486178

Group type: EXPERIMENTAL
Intervention: Sumatriptan 85 mg/naproxen sodium 500 mg
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study: 16866586

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo nicotine patch
Number of subjects: 70
Study: 12730150

Group type: EXPERIMENTAL
Intervention: nCPAP treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (age-matched infants)
Number of subjects: 18
Study: 11007576

Group type: EXPERIMENTAL
Intervention: CHO (2 g/kg body wt carbohydrate in a 10% solution)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ex (75 min of semirecumbent cycling exercise at 75% of peak O(2) consumption)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: ExCHO (Ex followed by ingestion of carbohydrate solution)
Number of subjects: 7
Study: 9084462

Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.2 mg/kg three times daily during 14 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 39
Study: 8452061

Group type: EXPERIMENTAL
Intervention: Ayre spatula used second
Number of subjects: 665

Group type: COMPARATOR
Intervention: Ayre spatula used first
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Curved brush used second
Number of subjects: 665

Group type: COMPARATOR
Intervention: Curved brush used first
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Curved brush
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Spatula
Number of subjects: 665
Study: 3961091

Group type: EXPERIMENTAL
Intervention: Individual short-term psychotherapy in combination with medical treatment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 103
Study: 31777210

Group type: EXPERIMENTAL
Intervention: Immersive simulation training every 6 weeks for 1 year
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group with 3 simulations at 3 time points (starting point, 6 months, and 1 year)
Number of subjects: 12
Study: 30168413

Group type: EXPERIMENTAL
Intervention: Hypothermia (32-35 °C)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 387
Study: 27777054

Group type: EXPERIMENTAL
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (no adjacent vertebral compression fracture)
Number of subjects: 139
Study: 25234311

Group type: EXPERIMENTAL
Intervention: ADPKD patients with eGFR >60 ml·min(‐1)·1.73 m(‐2)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: ADPKD patients
Number of subjects: 110

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 110
Study: 22558687

Group type: EXPERIMENTAL
Intervention: Colgate Sensitive Pro‐Relief toothpaste containing 8.0% arginine, 1450 ppm MFP and calcium carbonate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Colgate Cavity Protection toothpaste containing 1450 ppm MFP and calcium carbonate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both Test and Control groups
Number of subjects: 120
Study: 20883534

Group type: EXPERIMENTAL
Intervention: Cold, pulsatile machine perfusion (MP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Simple cold storage (CS)
Number of subjects: 90
Study: 19011772

Group type: EXPERIMENTAL
Intervention: Amino-acid infusion (4 kJ x kg(‐1) x h(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 24
Study: 16393718

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 948

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 948
Study: 12869077

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Infliximab with concomitant antimetabolite agents
Number of subjects: 30
Study: 10586170

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (1 to 2 RDA of elemental zinc 5 to 7 times per week)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (2 to 4 RDA daily for 2 weeks)
Number of subjects: 7
Study: 8725013

Group type: EXPERIMENTAL
Intervention: 0.08 mm RGP lens
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.12 mm RGP lens
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.16 mm RGP lens
Number of subjects: 17

Group type: COMPARATOR
Intervention: Hydrogel control lens
Number of subjects: 17
Study: 2067197

Group type: EXPERIMENTAL
Intervention: Cuprophane membrane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Polymethylmethacrylate (PMMA) membrane
Number of subjects: 8
Study: 6840172

Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with food (3566 kJ)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with dihydralazine 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Timolol maleate 10 mg with phenobarbitone 100 mg daily (1 week pretreatment)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Timolol maleate 10 mg with prazosin 1 mg
Number of subjects: 12
Study: 31161850

Group type: EXPERIMENTAL
Intervention: 3.75 mg/0.1 ml CTM gel
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1.88 mg/0.1 ml CTM
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30226112

Group type: EXPERIMENTAL
Intervention: Support for collaborative implementation planning (Community Engagement and Planning, CEP)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Technical support (Resources for Services, RS)
Number of subjects: 658
Study: 29056437

Group type: EXPERIMENTAL
Intervention: Text messaging intervention providing reproductive health information
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standardized discharge instructions (Control)
Number of subjects: 100
Study: 26019245

Group type: EXPERIMENTAL
Intervention: Calcium (600 mg/d) plus cholecalciferol (200 IU/d) supplementation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 25222307

Group type: EXPERIMENTAL
Intervention: Inactivated influenza A(H1N1)pdm09 vaccine (15 µg)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Inactivated influenza A(H1N1)pdm09 vaccine (30 µg)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 583
Study: 22706733

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 190

Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no MBP)
Number of subjects: 190
Study: 19305235

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention (self-monitored physical activity using a pedometer and step calendar, 2 behavioral counseling and goal-setting sessions)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 110
Study: 16697832

Group type: EXPERIMENTAL
Intervention: Central physician reviewers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Local physician reviewers
Number of subjects: 36
Study: 15477371

Group type: EXPERIMENTAL
Intervention: T gel 100 mg/d
Number of subjects: 406

Group type: COMPARATOR
Intervention: T gel 50 mg/d
Number of subjects: 406

Group type: COMPARATOR
Intervention: T patch
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 11245646

Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 430

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: ICD (in patients with low left ventricular ejection fraction <35%)
Number of subjects: 430

Group type: COMPARATOR
Intervention: ICD and Amiodarone (alternative extrapolations)
Number of subjects: 430
Study: 9192195

Group type: EXPERIMENTAL
Intervention: Inulin (soluble)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sugar beet fibre (partly soluble)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 9
Study: 7943065

Group type: EXPERIMENTAL
Intervention: Blunt expansion
Number of subjects: 286

Group type: COMPARATOR
Intervention: Sharp expansion
Number of subjects: 286
Study: 3280640

Group type: EXPERIMENTAL
Intervention: 1.5 million units of intravenous streptokinase
Number of subjects: 368

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 368
Study: 30738244

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 999

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: CRP ≥10 mg/L
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Baseline CRP modeled as a continuous log-transformed variable
Number of subjects: 999
Study: 28617765

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (traditional therapy)
Number of subjects: 100
Study: 25180530

Group type: EXPERIMENTAL
Intervention: Home hand-arm bimanual intensive therapy (H-HABIT), 90 hours provided by trained caregivers
Number of subjects: 11
Study: 23331333

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) treatment for an average of 4.8 months
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham treatment for an average of 4.4 months
Number of subjects: 58
Study: 20349856

Group type: EXPERIMENTAL
Intervention: Topography-guided PRK
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wavefront-optimized PRK
Number of subjects: 40
Study: 18242858

Group type: EXPERIMENTAL
Intervention: Exposure in vivo treatment (EXP)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Operant graded activity (GA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both treatments (EXP and GA)
Number of subjects: 85